A recent study has identified a potential new tool to help detect gastrointestinal cancers — the platelet-to-high-density lipoprotein ratio, or PHR. Researchers analyzed data from more than 19,000 ...
Gastrointestinal cancer cases are expected to double worldwide by 2050, according to a multi-institutional study co-led by ...
Comparing outcomes for early and late drainage of malignant ascites. Background: Black individuals, including African Americans, experience a disproportionate cancer burden and exhibit the lowest ...
A population-based study drew a possible connection between gastrointestinal (GI) symptoms and the multiple sclerosis (MS) prodrome. Patients with multiple sclerosis (MS) endure higher rates of drug ...
Capecitabine is an oral chemotherapy used to treat many gastrointestinal cancers. Its complex dosing and narrow therapeutic index make medication adherence and toxicity management crucial for quality ...
Among the most recently approved drugs for weight management, glucagon-like peptide 1 (GLP-1) agonists have garnered considerable attention; however, the effects of these drugs on the gastrointestinal ...
ALAMEDA, Calif.--(BUSINESS WIRE)--Exelixis, Inc. (Nasdaq: EXEL) today announced results from a subgroup analysis of the phase 3 CABINET pivotal study of patients with extra-pancreatic neuroendocrine ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results